$13.44
0.59% day before yesterday
NYSE, May 30, 10:07 pm CET
ISIN
US28414H1032
Symbol
ELAN

Elanco Animal Health, Inc. Stock price

$13.44
+3.96 41.77% 1M
-0.04 0.30% 6M
+1.33 10.98% YTD
-4.16 23.64% 1Y
-10.43 43.70% 3Y
-7.76 36.60% 5Y
-22.56 62.67% 10Y
NYSE, Closing price Fri, May 30 2025
-0.08 0.59%
ISIN
US28414H1032
Symbol
ELAN

Key metrics

Market capitalization $6.67b
Enterprise Value $10.58b
P/E (TTM) P/E ratio 17.92
EV/FCF (TTM) EV/FCF 31.78
EV/Sales (TTM) EV/Sales 2.39
P/S ratio (TTM) P/S ratio 1.51
P/B ratio (TTM) P/B ratio 1.05
Revenue growth (TTM) Revenue growth 1.42%
Revenue (TTM) Revenue $4.43b
EBIT (operating result TTM) EBIT $239.00m
Free Cash Flow (TTM) Free Cash Flow $333.00m
Cash position $487.00m
EPS (TTM) EPS $0.75
P/E forward negative
P/S forward 1.47
EV/Sales forward 2.33
Short interest 7.64%
Show more

Is Elanco Animal Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Elanco Animal Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Elanco Animal Health, Inc. forecast:

9x Buy
60%
6x Hold
40%

Analyst Opinions

15 Analysts have issued a Elanco Animal Health, Inc. forecast:

Buy
60%
Hold
40%

Financial data from Elanco Animal Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,427 4,427
1% 1%
100%
- Direct Costs 1,997 1,997
2% 2%
45%
2,430 2,430
1% 1%
55%
- Selling and Administrative Expenses 1,318 1,318
2% 2%
30%
- Research and Development Expense 351 351
5% 5%
8%
761 761
3% 3%
17%
- Depreciation and Amortization 522 522
5% 5%
12%
EBIT (Operating Income) EBIT 239 239
0% 0%
5%
Net Profit 373 373
129% 129%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Elanco Animal Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elanco Animal Health, Inc. Stock News

Neutral
PRNewsWire
4 days ago
GREENFIELD, Ind. , May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025.
Neutral
PRNewsWire
16 days ago
GREENFIELD, Ind. , May 16, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming investor conferences.
Neutral
Seeking Alpha
20 days ago
Elanco's shares have been pressured due to pipeline delays and debt from the Bayer acquisition, causing cautious optimism despite recent valuation resets. The company focuses on animal health, with balanced pet and livestock products, but struggles with debt and underwhelming growth since acquiring Bayer's animal health business. Despite some sales growth and debt reduction efforts, EBITDA and ...
More Elanco Animal Health, Inc. News

Company Profile

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.

Head office United States
CEO Jeffrey Simmons
Employees 9,225
Founded 1954
Website www.elanco.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today